Your browser is no longer supported. Please, upgrade your browser.
Settings
LJPC La Jolla Pharmaceutical Company daily Stock Chart
LJPC [NASD]
La Jolla Pharmaceutical Company
Index- P/E- EPS (ttm)-5.94 Insider Own5.00% Shs Outstand27.44M Perf Week-2.63%
Market Cap233.24M Forward P/E- EPS next Y-3.00 Insider Trans0.00% Shs Float25.51M Perf Month-22.16%
Income-158.30M PEG- EPS next Q-1.07 Inst Own- Short Float17.50% Perf Quarter-5.03%
Sales17.80M P/S13.10 EPS this Y-45.00% Inst Trans0.02% Short Ratio13.62 Perf Half Y18.72%
Book/sh-0.61 P/B- EPS next Y32.40% ROA-79.20% Target Price19.80 Perf Year-50.41%
Cash/sh4.50 P/C1.89 EPS next 5Y13.20% ROE-715.10% 52W Range5.01 - 18.11 Perf YTD-9.86%
Dividend- P/FCF- EPS past 5Y8.40% ROI-662.30% 52W High-52.73% Beta2.12
Dividend %- Quick Ratio5.90 Sales past 5Y- Gross Margin85.90% 52W Low70.86% ATR0.55
Employees169 Current Ratio6.00 Sales Q/Q256.30% Oper. Margin- RSI (14)35.95 Volatility5.20% 5.81%
OptionableYes Debt/Eq- EPS Q/Q44.30% Profit Margin- Rel Volume0.54 Prev Close8.50
ShortableYes LT Debt/Eq- EarningsOct 23 AMC Payout- Avg Volume327.61K Price8.56
Recom2.20 SMA20-7.43% SMA50-10.15% SMA2008.25% Volume35,274 Change0.71%
Jan-23-19Upgrade JP Morgan Underweight → Neutral
Jan-14-19Upgrade Jefferies Underperform → Hold
Feb-12-18Downgrade Jefferies Buy → Underperform
Jan-25-18Reiterated Chardan Capital Markets Neutral $90 → $100
Dec-26-17Reiterated SunTrust Buy $57 → $65
Dec-22-17Reiterated SunTrust Buy $67 → $65
Dec-22-17Reiterated H.C. Wainwright Buy $62 → $91
Dec-21-17Initiated H.C. Wainwright Buy $62
Dec-08-17Downgrade JP Morgan Overweight → Underweight
Aug-30-17Initiated JP Morgan Overweight $36
Feb-27-17Reiterated SunTrust Buy $38 → $57
Jun-22-16Initiated SunTrust Buy $30
May-24-16Initiated Lake Street Buy $25
Sep-08-15Reiterated Chardan Capital Markets Buy $60 → $80
Jul-07-15Reiterated Chardan Capital Markets Buy $54 → $60
May-11-15Reiterated H.C. Wainwright Buy $29 → $20
Apr-21-15Initiated Oppenheimer Outperform $43
Mar-20-15Reiterated H.C. Wainwright Buy $20 → $29
Mar-02-15Resumed Chardan Capital Markets Buy $54
Jul-09-14Reiterated Noble Financial Buy $34 → $38
Aug-29-19 09:00AM  La Jolla Pharmaceutical Company Receives European Commission Approval for GIAPREZA (angiotensin II) GlobeNewswire
Aug-16-19 02:38PM  GWU developed a life-saving drug. It just sold some royalty rights in an 8-figure deal. American City Business Journals
Aug-14-19 03:36PM  Does La Jolla Pharmaceutical (NASDAQ:LJPC) Have A Healthy Balance Sheet? Simply Wall St.
Aug-01-19 09:35AM  La Jolla Pharmaceutical (LJPC) Reports Q2 Loss, Lags Revenue Estimates Zacks
08:00AM  La Jolla Pharmaceutical Company Announces Financial Results for the Three and Six Months Ended June 30, 2019 and Highlights Recent Corporate Progress GlobeNewswire
Jul-30-19 11:53AM  Can GW Pharmaceuticals (GWPH) Deliver a Beat in Q2 Earnings? Zacks
11:31AM  CannTrust (CTST) to Report Q2 Earnings: What's in Store? Zacks
Jul-23-19 09:00AM  La Jolla Pharmaceutical Company Receives Orphan Designation from FDA for LJPC-0118 (Artesunate) for the Treatment of Malaria GlobeNewswire
Jul-01-19 08:39AM  La Jolla (LJPC) Secures Positive CHMP Opinion for Giapreza Zacks
Jun-28-19 06:30AM  La Jolla Pharmaceutical Company Receives Positive CHMP Opinion for GIAPREZA (angiotensin II) for the Treatment of Refractory Hypotension in Adults with Septic or Other Distributive Shock GlobeNewswire
Jun-11-19 11:55AM  Implied Volatility Surging for La Jolla Pharmaceutical (LJPC) Stock Options Zacks
Jun-07-19 02:02PM  Here's Why La Jolla Pharmaceutical Has More Than Doubled Over the Last 2 Days Motley Fool +25.59%
Jun-06-19 09:00AM  La Jolla Pharmaceutical Company Announces Positive Results from Pre-Specified Interim Analysis of Phase 2 Study of LJPC-401 in Patients with Hereditary Hemochromatosis GlobeNewswire +92.48%
May-22-19 01:49PM  How La Jolla Pharmaceutical Company (NASDAQ:LJPC) Can Impact Your Portfolio Volatility Simply Wall St.
May-06-19 06:25PM  La Jolla Pharmaceutical (LJPC) Reports Q1 Loss, Misses Revenue Estimates Zacks
05:15PM  La Jolla Pharmaceutical: 1Q Earnings Snapshot Associated Press
04:11PM  La Jolla Pharmaceutical Company Announces Financial Results for the Three Months Ended March 31, 2019 and Highlights Recent Corporate Progress GlobeNewswire
May-02-19 10:33AM  La Jolla Pharmaceutical (LJPC) May Report Negative Earnings: Know the Trend Ahead of Q1 Release Zacks
Apr-29-19 01:25PM  Consider These 3 Falling Knives GuruFocus.com +6.95%
Apr-24-19 09:00AM  La Jolla Pharmaceutical Company Announces U.S. FDAs Grant of Breakthrough Therapy Designation for LJPC-0118 for the Treatment of Severe Malaria GlobeNewswire
Mar-11-19 07:30AM  La Jolla Pharmaceutical Company Appoints Darryl Wellinghoff as Chief Commercial Officer GlobeNewswire
Mar-08-19 02:49PM  Edited Transcript of LJPC earnings conference call or presentation 4-Mar-19 9:30pm GMT Thomson Reuters StreetEvents
Mar-07-19 04:01PM  La Jolla Pharmaceutical Company to Present at the 39th Annual Cowen Healthcare Conference GlobeNewswire
01:05PM  Does La Jolla Pharmaceutical Companys (NASDAQ:LJPC) CEO Pay Reflect Performance? Simply Wall St.
Mar-06-19 08:56AM  Do Options Traders Know Something About La Jolla Pharmaceutical (LJPC) Stock We Don't? Zacks
Mar-05-19 07:24AM  The Daily Biotech Pulse: Novartis Psoriasis Drug Found Superior, Ascendis Offering, Adamas Earnings Benzinga +10.58%
Mar-04-19 06:33PM  La Jolla Pharmaceutical Co (LJPC) Q4 2018 Earnings Conference Call Transcript Motley Fool +8.76%
04:01PM  La Jolla Pharmaceutical Company Announces Financial Results for the Three and Twelve Months Ended December 31, 2018 and Highlights Recent Corporate Progress and Key Objectives GlobeNewswire
Feb-25-19 04:04PM  La Jolla Pharmaceutical Company to Release Fourth Quarter and Full Year 2018 Financial Results on March 4, 2019 GlobeNewswire
Feb-14-19 07:18PM  La Jolla Pharmaceutical Company Announces Data Presentations at the Society of Critical Care Medicines 48th Critical Care Congress GlobeNewswire
Feb-05-19 08:20AM  Analysis: Positioning to Benefit within ArcBest, International Game Technology, eHealth, Syros Pharmaceuticals, La Jolla Pharmaceutical, and Virtus Investment Partners Research Highlights Growth, Revenue, and Consolidated Results GlobeNewswire
Jan-18-19 07:00AM  Large Biotech Stock Holder Slashes Stake, but Insiders Are Buying Barrons.com
Jan-10-19 07:00AM  Biotech Companies to Watch ACCESSWIRE
Jan-09-19 11:28AM  HC Wainwright Slashes La Jolla Pharma Price Target, Estimates On Below-Expectation Guidance Benzinga +11.74%
Jan-07-19 10:25PM  Here's Why La Jolla Pharmaceutical Tumbled Today Motley Fool -50.19%
02:36PM  La Jolla Stock Plummets 44% After Disappointing Drug Sales Projections TheStreet.com
12:55PM  La Jolla Pharmaceutical's stock plummets to pace Nasdaq losers after downbeat drug guidance MarketWatch
09:00AM  La Jolla Pharmaceutical Company Highlights Recent Corporate Progress and Key Objectives GlobeNewswire
Jan-04-19 09:00AM  La Jolla Pharmaceutical Company to Present at the 37th Annual J.P. Morgan Healthcare Conference GlobeNewswire +7.79%
Dec-22-18 01:38AM  Hedge Funds Are Crazy About La Jolla Pharmaceutical Company (LJPC) Insider Monkey
Nov-06-18 08:35AM  Research Report Identifies Exelon, La Jolla Pharmaceutical, Kennedy-Wilson, Fluidigm, Telefonica SA, and Cognex with Renewed Outlook Fundamental Analysis, Calculating Forward Movement GlobeNewswire
Oct-31-18 12:04PM  Edited Transcript of LJPC earnings conference call or presentation 24-Oct-18 8:30pm GMT Thomson Reuters StreetEvents
Oct-25-18 03:55PM  3 Healthcare Stocks To Watch On Thursday ACCESSWIRE +15.96%
Oct-24-18 06:10PM  La Jolla Pharmaceutical (LJPC) Reports Q3 Loss, Tops Revenue Estimates Zacks -6.22%
05:06PM  La Jolla Pharmaceutical: 3Q Earnings Snapshot Associated Press
04:01PM  La Jolla Pharmaceutical Company Announces Financial Results for the Three and Nine Months Ended September 30, 2018 GlobeNewswire
07:48AM  The Daily Biotech Pulse: Illumina's Strong Q3, Celgene's Positive Cancer Drug Trial, Proteostasis Offering Benzinga
Oct-18-18 04:01PM  La Jolla Pharmaceutical Company to Release Third Quarter 2018 Financial Results on October 24, 2018 GlobeNewswire
Oct-16-18 11:21AM  Why You Need To Look At This Factor Before Buying La Jolla Pharmaceutical Company (NASDAQ:LJPC) Simply Wall St. +6.83%
07:25AM  Recent Analysis Shows Professional Diversity Network, Quanex Building Products, HTG Molecular Diagnostics, La Jolla Pharmaceutical, Playa Hotels & Resorts N.V, and Plexus Market Influences Renewed Outlook, Key Drivers of Growth GlobeNewswire
Aug-16-18 08:00AM  Factors of Influence in 2018, Key Indicators and Opportunity within Celsion, Alpha and Omega Semiconductor, SP Plus, Merrimack Pharmaceuticals, La Jolla Pharmaceutical, and SPX New Research Emphasizes Economic Growth GlobeNewswire +9.10%
Aug-13-18 03:35PM  Edited Transcript of LJPC earnings conference call or presentation 8-Aug-18 8:30pm GMT Thomson Reuters StreetEvents
Aug-09-18 12:51PM  Why La Jolla Pharmaceutical Is Tumbling Today Motley Fool -25.39%
Aug-08-18 08:00PM  La Jolla Pharmaceutical (LJPC) Reports Q2 Loss, Misses Revenue Estimates Zacks +5.47%
06:55PM  La Jolla Pharmaceutical: 2Q Earnings Snapshot Associated Press
04:01PM  La Jolla Pharmaceutical Company Announces Financial Results for the Three and Six Months Ended June 30, 2018 and Recent Corporate Progress GlobeNewswire
02:30PM  La Jolla Pharmaceutical Company to Host Earnings Call ACCESSWIRE
Aug-03-18 09:00AM  La Jolla Pharmaceutical Company Announces Receipt of New Technology Add-on Payment Coverage for GIAPREZA GlobeNewswire
Aug-01-18 05:39PM  La Jolla Pharmaceutical Company to Release Second Quarter 2018 Financial Results and Host a Webcasted Conference Call on August 8, 2018 GlobeNewswire
Jul-16-18 07:05AM  Free Technical Research on Marinus Pharma and Three More Biotech Equities ACCESSWIRE
Jun-25-18 09:00AM  La Jolla Pharmaceutical Company Announces European Medicines Agency Validation of Marketing Authorisation Application for GIAPREZA (angiotensin II) GlobeNewswire
Jun-15-18 02:39PM  2 Stable and 2 Speculative Biotech Stocks to Buy InvestorPlace
07:09AM  Iovance Biotherapeutics and Three Additional Biotech Stocks on Our Research Desk's Radar ACCESSWIRE
May-21-18 08:25AM  Recent Analysis Shows Engility, La Jolla Pharmaceutical, Freshpet, At Home Group, Denny's, and SP Plus Market Influences Renewed Outlook, Key Drivers of Growth GlobeNewswire
May-17-18 01:00PM  La Jolla Pharmaceutical Company Announces LJPC-401 Presentations at 23rd Congress of the European Hematology Association GlobeNewswire
May-11-18 07:05AM  Complimentary Stock Performance Review on La Jolla Pharma and Three Additional Biotech Industry Stocks ACCESSWIRE -6.58%
May-10-18 09:23PM  What Should We Expect From La Jolla Pharmaceutical Companys (NASDAQ:LJPC) Earnings In The Next Couple Of Years? Simply Wall St.
07:53PM  La Jolla Pharmaceutical: 1Q Earnings Snapshot Associated Press
04:46PM  La Jolla Pharmaceutical Company Announces $125 Million Royalty Financing Agreement with HealthCare Royalty Partners GlobeNewswire
04:45PM  La Jolla Pharmaceutical Company Announces Financial Results for the Three Months Ended March 31, 2018 and Recent Corporate Progress GlobeNewswire
May-01-18 05:15PM  CalciMedica Names Two Senior Executives to its Board of Directors PR Newswire
Mar-30-18 08:00AM  [$$] 3 Biotech Stocks a Pro Is Buying Now Barrons.com
Mar-23-18 07:40AM  Market Trends Toward New Normal in La Jolla Pharmaceutical, AquaVenture, Duluth, Community Bank System, Cubic, and TrustCo Bank Corp NY Emerging Consolidated Expectations, Analyst Ratings GlobeNewswire
Mar-22-18 04:01PM  La Jolla Pharmaceutical Company Announces Launch of GIAPREZA (angiotensin II) in the United States GlobeNewswire
Mar-15-18 08:00AM  La Jolla Pharmaceutical Company Announces Pricing of Public Offering of Common Stock GlobeNewswire
Mar-14-18 04:01PM  La Jolla Pharmaceutical Company Announces $100 Million Public Offering of Common Stock GlobeNewswire -8.21%
Mar-06-18 02:40PM  GIAPREZA (angiotensin II) Significantly Improved Survival and Reduced Time on Renal Replacement Therapy in Patients with Acute Kidney Injury GlobeNewswire
Feb-25-18 09:00AM  GIAPREZA (angiotensin II) Significantly Improved Survival of Patients with High APACHE II Scores in ATHOS-3 Study GlobeNewswire
Feb-23-18 05:02AM  La Jolla Pharmaceutical posts 4Q loss Associated Press
Feb-22-18 05:17PM  La Jolla Pharmaceutical Company Announces Financial Results for the Three and Twelve Months Ended December 31, 2017 and Recent Corporate Progress GlobeNewswire
Feb-21-18 09:00AM  La Jolla Pharmaceutical Company Announces the Treatment of First Patient in GIAPREZA (angiotensin II) Pediatric Study GlobeNewswire
Feb-12-18 04:35PM  Why Lumber Liquidators Holdings, Stamps.com, and La Jolla Pharmaceutical Slumped Today Motley Fool -13.09%
11:04AM  Jefferies Downgrades La Jolla On Weak Forecast For Blood Pressure Drug Benzinga
Feb-02-18 02:39PM  What You Must Know About La Jolla Pharmaceutical Companys (NASDAQ:LJPC) Financial Health Simply Wall St. +7.67%
Jan-24-18 08:00AM  Consolidated Research: 2018 Summary Expectations for Freshpet, eHealth, SEACOR, La Jolla Pharmaceutical, Rogers, and On Assignment Fundamental Analysis, Key Performance Indications GlobeNewswire
Jan-03-18 03:00AM  La Jolla Pharmaceutical Hits 80-Plus Relative Strength Rating Benchmark Investor's Business Daily
Dec-29-17 09:00PM  3 Biotechs Launching Their First Commercial Drugs in 2018 Motley Fool
Dec-28-17 07:19AM  La Jolla Pharmaceutical Co. is trading above its 50 day moving average : LJPC-US : December 28, 2017 Capital Cube
Dec-26-17 08:36AM  La Jolla Pharmaceutical (LJPC) Surges: Stock Moves 11.1% Higher Zacks
Dec-22-17 04:13PM  Christmas Comes Early For These 5 Biotechnology Stocks Investor's Business Daily +11.13%
12:20PM  What the Latest Approval Means for La Jolla Pharmaceutical GuruFocus.com
12:16PM  Here's Why La Jolla Pharmaceutical Shares Are Surging 12.5% Higher Today Motley Fool
Dec-21-17 06:36PM  La Jolla stock jumps 16% after FDA approval MarketWatch
06:35PM  FDA approves La Jolla's low blood pressure drug Reuters
06:15PM  La Jolla Pharmaceutical Company Announces FDA Approval of Giapreza (angiotensin II) GlobeNewswire
11:58AM  Analyst: La Jolla Pharma A Buy Ahead Of February FDA Date Benzinga
Dec-19-17 05:35AM  [$$] 5 Biotech Stocks a Pro Is Buying Barrons.com
Dec-18-17 09:00AM  La Jolla Pharmaceutical Company Announces Initiation of Multicenter, Randomized, Phase 2 Clinical Study of LJPC401 in Patients with Hereditary Hemochromatosis GlobeNewswire
Dec-11-17 08:10AM  Todays Research Reports on Stocks to Watch: Soleno Therapeutics and La Jolla Pharmaceutical Company ACCESSWIRE
Dec-08-17 01:54PM  Here's What's Causing Investors to Sell La Jolla Pharmaceutical Shares Today Motley Fool -15.03%
La Jolla Pharmaceutical Company, a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for life-threatening diseases. The company offers GIAPREZA (angiotensin II), an injection for intravenous infusion indicated to increase blood pressure in adults with septic or other distributive shock. It is also developing LJPC-0118 for the treatment of severe malaria; and LJPC-401 (synthetic human hepcidin), a clinical-stage investigational product to treat conditions characterized by iron overload, including hereditary hemochromatosis, beta thalassemia, sickle cell disease, myelodysplastic syndrome, and polycythemia vera. The company was founded in 1989 and is headquartered in San Diego, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Chawla Lakhmir SChief Medical OfficerJan 30Buy5.571,0005,5705,259Jan 31 06:49 PM
Chawla Lakhmir SChief Medical OfficerJan 29Buy5.562,00011,1244,259Jan 31 06:49 PM
TANG KEVIN CDirectorJan 09Buy5.5479,214438,8064,938,893Jan 09 09:54 PM
Rolke JamesChief Scientific OfficerJan 09Buy6.091,6009,74676,330Jan 09 09:28 PM
CARVER JENNIFERChief Operating OfficerJan 09Buy6.175,00030,82512,116Jan 09 09:29 PM
TANG KEVIN CDirectorJan 08Buy5.321,120,7865,962,6394,859,679Jan 09 09:54 PM
PERCEPTIVE ADVISORS LLC10% OwnerJan 08Sale5.251,250,2356,568,2362,253,376Jan 09 07:37 PM
TANG KEVIN CDirectorJan 07Buy5.84100,000583,8403,738,893Jan 09 09:54 PM
TIDMARSH GEORGE FPresident, CEO & SecretaryJan 07Buy5.852,00011,7001,283,326Jan 09 09:29 PM
PERCEPTIVE ADVISORS LLC10% OwnerJan 07Sale6.36810,0005,147,7493,503,611Jan 09 07:37 PM